✦ LIBER ✦

Predictors for Success in a Phase III Trial—an Analysis of 315 Phase II Chemotherapy Trials for Advanced Cancers

✍ Scribed by S.M. Ueda; D.S. Kapp; V.E. Sugiyama; C. Stave; J.Y. Shin; B.J. Monk; B.I. Sikic; K. Osann; J.K. Chan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Eligibility of patients with advanced no

✍ Janette Vardy; Ryan Dadasovich; Philip Beale; Michael Boyer; Stephen J Clarke 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 187 KB

Phase II trial of paclitaxel and cisplat

✍ Tsuburaya, Akira; Nagata, Naoki; Cho, Haruhiko; Hirabayashi, Naoki; Kobayashi, M 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 206 KB

Taxanes for Breast Cancer: An Evidence-B

✍ Joseph A. Sparano 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 133 KB

Meta-analysis of Phase III randomized tr

✍ Karim M. Eltawil; Paul D. Renfrew; Michele Molinari 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB

An EORTC randomized phase III trial of t

✍ E.F. Smit; J.P. van Meerbeeck; P. Lianes; F. Schramel; G. Lenz 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Should chemotherapy combinations for adv

✍ Pujol, Jean-Louis; Barlesi, Fabrice; Daurès, Jean-Pierre 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 163 KB